Literature DB >> 3547499

Platelet-inhibitor drugs' role in coronary artery disease.

V Fuster, P C Adams, J J Badimon, J H Chesebro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3547499     DOI： 10.1016/0033-0620(87)90001-6

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  6 in total

1.  Aspirin and thrombolytic therapy for acute myocardial infarction. Should the combination now be a routine therapy?

Authors:  T L Schreiber
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 2.  Modification of atherosclerosis by agents that do not lower cholesterol.

Authors:  J G Cleland; D M Krikler
Journal:  Br Heart J       Date:  1993-01

Review 3.  Antiplatelet therapy--Part I.

Authors:  S H Goodnight; B M Coull; J H McAnulty; L M Taylor
Journal:  West J Med       Date:  1993-04

4.  Platelet-reactive sites in collagens type I and type III. Evidence for separate adhesion and aggregatory sites.

Authors:  L F Morton; A R Peachey; M J Barnes
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

5.  Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty.

Authors:  P Urban; N Buller; K Fox; L Shapiro; J Bayliss; A Rickards
Journal:  Br Heart J       Date:  1988-12

6.  Little impact of antiplatelet agents on venous thromboembolism after hip fracture surgery.

Authors:  Hyung-Min Ji; Young-Kyun Lee; Yong-Chan Ha; Ki-Choul Kim; Kyung-Hoi Koo
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.